Enact Holdings, Inc. (ACT)

Secondary debt liquidity for ACT proxies remains highly resilient despite headline noise. Watching gross margin expansion.

On our desk, the valuation picture for Enact Holdings (ACT) looks steady yet capped. Trading around $47.89 to $48.67 with an average analyst price target sitting near $47.40 to $49, the stock is currently registering a Hold or Neutral consensus from major houses like JPMorgan. While the company posted solid Q2 2026 adjusted operating income of $1.26 per share and robust capital returns including a $0.24 quarterly dividend, the 80%+ ownership stake by Genworth Financial remains a structural overhang. Institutional investors continue to debate whether this parent-subsidiary dynamic creates a permanent valuation discount, limiting the multiple expansion despite exceptional PMIERs sufficiency ratios over 160%.

From a risk management standpoint, ACT operates in a highly sensitive niche. As a mono-line mortgage insurance provider, its portfolio is directly exposed to U.S. macroeconomic shifts, housing affordability, and mortgage rate volatility. Although their loss ratio stayed remarkably low at 14% in Q2 2026 and new insurance written climbed to $15.2 billion, any broader economic recession or housing market correction could quickly test their conservative reserve assumptions. Furthermore, flat year-over-year revenue trends in recent quarters indicate that organic top-line growth could face structural limitations if interest rates remain elevated.

When evaluating ACT's underwriting and capital framework for technical mandates, analysts must look closely at their GSE eligibility metrics. Enact maintains a very strong capital buffer with nearly $1.9 billion above PMIERs requirements, demonstrating disciplined risk management and underwriting quality. However, financial models should incorporate the reality of slow historical net premiums earned growth and potential demand deceleration over the next 12 months. When pitching or defending positions on this ticker, focus on their operational efficiency, book value per share growth of 12.2% year-over-year, and how they balance share buybacks against broader macro credit risks.